Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral Neck

View ORCID ProfileKendall J. Kiser, Anthony J. Apicelli, Randall J. Brenneman, Jessika A. Contreras, Hiram Gay, Michael J. Moravan, Nikhil Rammohan, Ryan S. Jackson, Patrik Pipkorn, Sidharth V. Puram, Jason T. Rich, Jose P. Zevallos, Douglas R. Adkins, Peter Oppelt, Wade L. Thorstad
doi: https://doi.org/10.1101/2024.05.16.24307485
Kendall J. Kiser
1Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kendall J. Kiser
Anthony J. Apicelli
1Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randall J. Brenneman
2Springfield Clinic Cancer Center, Springfield, IL
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessika A. Contreras
1Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiram Gay
1Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Moravan
1Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikhil Rammohan
1Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan S. Jackson
3Department of Otolaryngology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrik Pipkorn
3Department of Otolaryngology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sidharth V. Puram
3Department of Otolaryngology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason T. Rich
3Department of Otolaryngology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD, FACS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose P. Zevallos
4Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA
MD, MPH, FACS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas R. Adkins
5Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Oppelt
5Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wade L. Thorstad
1Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: thorstad{at}wustl.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction In 2019 we published a phase II trial of ipsilateral neck adjuvant radiation therapy in head and neck (HN) carcinoma patients with a pathologically negative (pN0) contralateral neck after bilateral neck dissection. The five-year contralateral neck recurrence rate was 3%. Here we present the recurrence rate in patients subsequently treated by this trial’s paradigm.

Methods Patients were selected who would have been eligible for our phase II trial: all had oropharynx, hypopharynx, oral cavity, or unknown primary carcinomas without prior HN cancer or major HN surgeries, underwent primary resection including bilateral neck dissection with a pN0 contralateral neck, and underwent adjuvant intensity modulated radiation therapy (IMRT) that spared the contralateral neck.

Results Fifty-five patients met cohort inclusion criteria. Thirty-nine cancers arose from the oropharynx, 11 from the oral cavity, three from the hypopharynx, and two from an unknown primary. With a median follow-up of 15 months there were nine recurrences (16%), four contralateral neck recurrences (7%), and one isolated contralateral neck recurrence (2%). No contralateral neck recurrences occurred in patients with p16+ oropharyngeal primaries despite that most (73%) arose from the base of the tongue. In contrast, three contralateral neck recurrences occurred in patients with advanced stage oral cavity primaries.

Conclusion The contralateral neck recurrence rate in HN carcinoma patients with a pN0 contralateral neck treated by adjuvant ipsilateral neck IMRT was similar to the 3% rate observed in our phase II trial. However, this paradigm may be inadequate for patients with locally advanced oral cavity primaries.

Competing Interest Statement

Hiram Gay receives honoraria from Boston Scientific. Ryan Jackson receives honoraria from Intuitive, Inc. Peter Oppelt receives research funding and salary support from Merck and HiFiBio. The remaining authors report no disclosures.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Human Research Protection Office Institutional Review Board of the Washington University School of Medicine gave ethical approval for this work (#202305057).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 16, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral Neck
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral Neck
Kendall J. Kiser, Anthony J. Apicelli, Randall J. Brenneman, Jessika A. Contreras, Hiram Gay, Michael J. Moravan, Nikhil Rammohan, Ryan S. Jackson, Patrik Pipkorn, Sidharth V. Puram, Jason T. Rich, Jose P. Zevallos, Douglas R. Adkins, Peter Oppelt, Wade L. Thorstad
medRxiv 2024.05.16.24307485; doi: https://doi.org/10.1101/2024.05.16.24307485
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral Neck
Kendall J. Kiser, Anthony J. Apicelli, Randall J. Brenneman, Jessika A. Contreras, Hiram Gay, Michael J. Moravan, Nikhil Rammohan, Ryan S. Jackson, Patrik Pipkorn, Sidharth V. Puram, Jason T. Rich, Jose P. Zevallos, Douglas R. Adkins, Peter Oppelt, Wade L. Thorstad
medRxiv 2024.05.16.24307485; doi: https://doi.org/10.1101/2024.05.16.24307485

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)